Conditionally-Replicating Adenovirus Expressing TIMP2 for Ovarian Cancer Therapy

PURPOSE: Current treatments for ovarian cancers have limited therapeutic outcomes due to advanced stage of the disease at diagnosis. Among new therapies, conditionally-replicating adenoviruses (CRAds), designed to selectively lyse cancer cells, hold promise. In clinical trials, CRAds exhibited limit...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yang, Sherry W., Cody, James J., Rivera, Angel A., Waehler, Reinhard, Wang, Minghui, Kimball, Kristopher J., Alvarez, Ronald A., Siegal, Gene P., Douglas, Joanne T., Ponnazhagan, Selvarangan
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3816714/
https://ncbi.nlm.nih.gov/pubmed/21115652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-1628
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires